Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

BEAM holding history

Beam Therapeutics Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings

Shares (Q2 2026)
16,351
Value
$561.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BEAM by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,351$561.2K<0.1%−2,066−11.2%ReducedHolders
Q1 202618,417$438.9K<0.1%−3,528−16.1%ReducedHolders
Q4 202521,945$608.3K<0.1%+1,991+10.0%AddedHolders
Q3 202519,954$484.3K<0.1%−3,408−14.6%ReducedHolders
Q2 202523,362$397.4K<0.1%−214−0.9%ReducedHolders
Q1 202523,576$460.4K<0.1%−1,870−7.3%ReducedHolders
Q4 202425,446$631.1K<0.1%+6,127+31.7%AddedHolders
Q3 202419,319$473.3K<0.1%+4,247+28.2%AddedHolders
Q2 202415,072$353.1K<0.1%−4,439−22.8%ReducedHolders
Q1 202419,511$644.6K<0.1%+1,873+10.6%AddedHolders
Q4 202317,638$480.1K<0.1%+3,399+23.9%AddedHolders
Q3 202314,239$342.4K<0.1%+419+3.0%AddedHolders
Q2 202313,820$441.3K<0.1%+880+6.8%AddedHolders
Q1 202312,940$396.2K<0.1%−1,961−13.2%ReducedHolders
Q4 202214,901$582.8K<0.1%+1,036+7.5%AddedHolders
Q3 202213,865$661.0K<0.1%+494+3.7%AddedHolders
Q2 202213,371$516.0K<0.1%−4,376−24.7%ReducedHolders
Q1 202217,747$1.02M<0.1%−4,156−19.0%ReducedHolders
Q4 202121,903$1.75M<0.1%+304+1.4%AddedHolders
Q3 202121,599$1.88M<0.1%−1,834−7.8%ReducedHolders
Q2 202123,433$3.02M<0.1%+4,726+25.3%AddedHolders
Q1 202118,707$1.50M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.